U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114406) titled 'A Study to Evaluate Safety and Efficacy of PBK_M2502' on May 21.

Brief Summary: This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Intestinal Disease Colonic Diseases Gastrointestinal Disease Digestive System Disease

Intervention: DRUG: PBK_M2502 1-Day

Subjects who are randomized into group test 2 will receive bowel preparation on the same-day.

DRUG: PBK_M2502 2-Day

Subjects who are randomized into group test 1 will receive bowel...